CAS 329003-65-8

Risedremate Sodium

Description:

Risedremate sodium, with the CAS number 329003-65-8, is a chemical compound primarily recognized for its application in the treatment of osteoporosis. It functions as a selective estrogen receptor modulator (SERM), which means it can mimic estrogen's beneficial effects on bone density while minimizing potential side effects associated with estrogen therapy. This compound exhibits a unique mechanism of action, promoting bone formation and inhibiting bone resorption, thus contributing to improved bone health. Risedremate sodium is typically administered orally and is characterized by its stability under standard conditions. Its pharmacokinetics involve absorption in the gastrointestinal tract, with a distribution that allows it to exert effects on bone tissue. The compound is generally well-tolerated, with a safety profile that has been evaluated in clinical studies. As with any medication, potential side effects and contraindications should be considered, and it is essential for patients to consult healthcare professionals for personalized advice regarding its use.

Formula: C₇H₁₀NO₇P₂NaH₂O

Synonyms:

• Monosodium Risedronate

Monosodium Risedronate Hemipentahydrate

CAS: 105462-24-6, 115436-72-1, 329003-65-8

Formula: C₇H₁₀NNaO₇P₂H₂O

Purity: >98.0%(T)(HPLC)

Color and Shape: White to Almost white powder to crystal

Molecular weight: 350.13

Ref: 3B-M2289

Risedronate sodium 2.5-hydrate

CAS: 329003-65-8

Risedronate sodium 2.5-hydrate

Formula: C₇H₁₀NNaO₇P₂

Purity: 86.2%

Color and Shape: White

Molecular weight: 304.98302

Ref: 47-1241

RISEDRONATE SODIUM 2.5-HYDRATE CRS

CAS: 329003-65-8

RISEDRONATE SODIUM 2.5-HYDRATE CRS

Formula: C₇H₁₀NNaO₇P₂

Color and Shape: Powder

Molecular weight: 305.0941

Ref: 41-Y0001541

Risedronate Sodium

CAS: 329003-65-8

Compounds containing an unfused pyridine ring in the structure, nesoi

Formula: C₇H₁₀NNaO₇P₂·5H₂O

Color and Shape: White Crystalline Powder

Molecular weight: 291.012

Ref: 45-1604610

Sodium hydrogen(1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate hydrate(2:2:5)

CAS: 329003-65-8

Formula: C₁₄H₃₀N₂NaO₁₉P₄

Purity: 98%

Molecular weight: 677.2748

Ref: IN-DA003S5Y

Monosodium Risedronate Hemipentahydrate

CAS: 329003-65-8

Monosodium Risedronate Hemipentahydrate

Purity: >98.0%

Ref: 54-OR1079366

Risedronate Sodium 2.5 Hydrate

CAS: 329003-65-8

Color and Shape: Neat

Ref: 61-FOR0777.00

Risedronate Sodium 2.5 Hydrate

Controlled Product

CAS: 329003-65-8

Formula: C₇H₁₀NO₇P₂NaH₂O

Color and Shape: Neat

Molecular weight: 700.26

Ref: 86-MM0777.00

Risedronate sodium hydrate

CAS: 329003-65-8

Risedronate sodium hydrate is a polymorphic, water-soluble salt of risedronate. It has been used in the treatment of osteoporosis and Paget's disease of bone. Risedronate sodium hydrate binds to calcium ions in the body and prevents them from being deposited in bone tissue. This drug also cross-links collagen fibers in the bone matrix, which increases mineralization and decreases the risk of fracture by strengthening the bones. The monosodium salt form of risedronate is soluble in water and is used as an analytical reagent for determining ionic strength or pH. It has been shown to inhibit ionotropic gelation, which may be due to its polyphosphoric acid content. Risedronate sodium hydrate is a polymorphic, water-soluble salt of risedronate that has been used in the treatment of osteoporosis and Paget's disease of bone. Risedronate sodium hyd

Formula: C₇H₁₀NNaO₇P₂·xH₂O

Purity: Min. 98 Area-%

Color and Shape: Powder

Molecular weight: 350.13 g/mol

Ref: 3D-IM57822